Table 2: Hematological parameters in selected patients harboring the (αTSaudi(α/(αHph(α) genotype
| No. |
Gender/Age |
Hb
(g/dL)
|
RBC
(x1012/L)
|
MCV
(fL)
|
MCH
(pg)
|
MCHC
(g/dL)
|
HbA2
(%)
|
| 1 |
M/45 |
10.9 |
6.1 |
57.7 |
17.8 |
30.8 |
2.3 |
| 2 |
F/35 |
9.9 |
5.5 |
58.2 |
18.0 |
30.9 |
2.5 |
| 3 |
F/30 |
9.2 |
4.8 |
59.4 |
18.8 |
31.6 |
2.4 |
| 4 |
F/49 |
10.3 |
5.3 |
58.0 |
19.2 |
33.1 |
2.1 |
| 5 |
F/10 |
9.2 |
5.0 |
58.3 |
18.3 |
31.4 |
2.5 |
| 6 |
F/14 |
9.9 |
5.4 |
60.0 |
19.0 |
31.0 |
2.1 |
| 7 |
M/9 |
9.9 |
5.5 |
61.0 |
18.0 |
30.0 |
2.2 |
| 8 |
M/9 |
9.0 |
5.4 |
55.7 |
16.8 |
30.1 |
2.1 |
| 9 |
F/43 |
9.4 |
4.8 |
61.9 |
19.5 |
31.5 |
2.2 |
| 10 |
F/70 |
9.8 |
5.2 |
59.6 |
18.7 |
31.4 |
2.5 |
| 11 |
M/7 |
9.0 |
4.9 |
57.8 |
18.4 |
31.9 |
2.6 |
| 12 |
F/19 |
9.4 |
5.7 |
54.0 |
17.0 |
31.0 |
2.0 |
| 13 |
F/21 |
10.1 |
5.2 |
61.2 |
19.4 |
31.7 |
2.2 |
| 14 |
F/23 |
10.8 |
5.7 |
60.0 |
19.1 |
31.9 |
2.1 |
| 15 |
M/61 |
11.3 |
6.0 |
60.0 |
18.0 |
30.0 |
2.3 |
*ND: Not Determined